Keywords: mylan, swings, 2nd-qtr, loss, merck, usa-based, swung

Mylan swings to a 2nd-qtr 2008 loss on Merck

Article | 18 August 2008

Print This

USA-based Mylan swung to a loss in the second quarter of 2008, due to the cost of the generic drugs unit ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in